Still early days, and real-world data will be essential
Singh M, Mansuri MS, Kadam A, Palit SP, Dwivedi M, Laddha NC, et al
As your dedicated partner, we combine deep industry knowledge with innovative thinking to ensure your business remains resilient and competitive
These sources were used to collect prescription volume statistics, regulatory approval data, clinical safety and efficacy studies from landmark trials (SUSTAIN, STEP, SELECT), epidemiological data on diabetes and obesity prevalence, pricing and reimbursement landscapes, and competitive intelligence for injectable versus oral semaglutide formulations, as well as emerging GLP-1 receptor agonist therapies